RESEARCH TRIANGLE PARK – IBM’s long rumored sale of assets from its artificial intelligence-based Watson Health business became reality Friday morning. Big Blue announced the sale of its healthcare data and analytics assets to private equity firm Francisco Partners. Sold assets include “extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings,” IBM noted. “Today’s agreement with Francisco Partners is a clear next step as IBM becomes even more focused on our platform-based hybrid cloud and AI strategy,” said Tom Rosamilia, Senior Vice President, IBM Software, in the announcement. “IBM remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.

Source: Wall Street Journal January 21, 2022 16:27 UTC